|
1
|
Ferlay J, Ervik M, Lam F, Laversanne M,
Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I and Bray F:
Global cancer observatory: Lip, oral cavity. International Agency
for Research on Cancer, Lyon, 2024. https://gco.iarc.who.int/today/en/fact-sheets-cancers.
|
|
2
|
Bosetti C, Carioli G, Santucci C,
Bertuccio P, Gallus S, Garavello W, Negri E and La Vecchia C:
Global trends in oral and pharyngeal cancer incidence and
mortality. Int J Cancer. 147:1040–1049. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Eboshida N, Hamada A, Higaki M, Obayashi
F, Ito N, Yamasaki S, Tani R, Shintani T, Koizumi K and Yanamoto S:
Potential role of circulating tumor cells and cell-free DNA as
biomarkers in oral squamous cell carcinoma: A prospective
single-center study. PLoS One. 19(e0309178)2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Morris LGT, Chandramohan R, West L, Zehir
A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS,
et al: The molecular landscape of recurrent and metastatic head and
neck cancers: Insights from a precision oncology sequencing
platform. JAMA Oncol. 3:244–255. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Saito Y, Kage H, Kobayashi K, Yoshida M,
Fukuoka O, Yamamura K, Mukai T, Oda K and Yamasoba T: TERT promoter
mutation positive oral cavity carcinomas, a clinically and
genetically distinct subgroup of head and neck squamous cell
carcinomas. Head Neck. 45:3107–3118. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rayess H, Wang MB and Srivatsan ES:
Cellular senescence and tumor suppressor gene p16. Int J Cancer.
130:1715–1725. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Landrum MJ, Lee JM, Benson M, Brown GR,
Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, et al:
ClinVar: Improving access to variant interpretations and supporting
evidence. Nucleic Acids Res. 46 (D1):D1062–D1067. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lydiatt WM, Patel SG, O'Sullivan B,
Brandwein MS, Ridge JA, Migliacci JC, Loomis AM and Shah JP: Head
and Neck cancers-major changes in the American joint committee on
cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:122–137. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nguyen TQ, Hamada A, Yamada K, Higaki M,
Shintani T, Yoshioka Y, Toratani S and Okamoto T: Enhanced KRT13
gene expression bestows radiation resistance in squamous cell
carcinoma cells. In Vitro Cell Dev Biol Anim. 57:300–314.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shelton J, Purgina BM, Cipriani NA, Dupont
WD, Plummer D and Lewis JS Jr: p16 immunohistochemistry in
oropharyngeal squamous cell carcinoma: A comparison of antibody
clones using patient outcomes and high-risk human papillomavirus
RNA status. Mod Pathol. 30:1194–1203. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ribeiro EA and Maleki Z: p16
immunostaining in cytology specimens: Its application, expression,
interpretation, and challenges. J Am Soc Cytopathol. 10:414–422.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ogino S, Kawasaki T, Kirkner GJ, Yamaji T,
Loda M and Fuchs CS: Loss of nuclear p27 (CDKN1B/KIP1) in
colorectal cancer is correlated with microsatellite instability and
CIMP. Mod Pathol. 20:15–22. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Loizou E, Banito A, Livshits G, Ho YJ,
Koche RP, Sánchez-Rivera FJ, Mayle A, Chen CC, Kinalis S, Bagger
FO, et al: A gain-of-function p53-mutant oncogene promotes cell
fate plasticity and myeloid leukemia through the pluripotency
factor FOXH1. Cancer Discov. 9:962–979. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yu X, Mao SQ, Shan YY, Huang Y, Wu SD and
Lu CD: Predictive value of the TP53. p.G245S mutation frequency for
the short-term recurrence of hepatocellular carcinoma as detected
by pyrophosphate sequencing. Genet Test Mol Biomarkers. 26:476–484.
2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lindenbergh-van der Plas M, Brakenhoff RH,
Kuik DJ, Buijze M, Bloemena E, Snijders PJ, Leemans CR and
Braakhuis BJ: Prognostic significance of truncating TP53 mutations
in head and neck squamous cell carcinoma. Clin Cancer Res.
17:3733–3741. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kannengiesser C, Brookes S, del Arroyo AG,
Pham D, Bombled J, Barrois M, Mauffret O, Avril MF, Chompret A,
Lenoir GM, et al: Functional, structural, and genetic evaluation of
20 CDKN2A germ line mutations identified in melanoma-prone families
or patients. Hum Mutat. 30:564–574. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fakhry C, Westra WH, Li S, Cmelak A, Ridge
JA, Pinto H, Forastiere A and Gillison ML: Improved survival of
patients with human papillomavirus-positive head and neck squamous
cell carcinoma in a prospective clinical trial. J Natl Cancer Inst.
100:261–269. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hong AM, Dobbins TA, Lee CS, Jones D,
Harnett GB, Armstrong BK, Clark JR, Milross CG, Kim J, O'Brien CJ
and Rose BR: Human papillomavirus predicts outcome in oropharyngeal
cancer in patients treated primarily with surgery or radiation
therapy. Br J Cancer. 103:1510–1517. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ni Y, Zhang X, Wan Y, Dun Tang K, Xiao Y,
Jing Y, Song Y, Huang X, Punyadeera C and Hu Q: Relationship
between p16 expression and prognosis in different anatomic subsites
of OSCC. Cancer Biomark. 26:375–383. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liggett WH Jr and Sidransky D: Role of the
p16 tumor suppressor gene in cancer. J Clin Oncol. 16:1197–1206.
1998.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hara E, Smith R, Parry D, Tahara H, Stone
S and Peters G: Regulation of p16CDKN2 expression and its
implications for cell immortalization and senescence. Mol Cell
Biol. 16:859–867. 1996.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shi WK, Li YH, Bai XS and Lin GL: The cell
cycle-associated protein CDKN2A may promotes colorectal cancer cell
metastasis by inducing epithelial-mesenchymal transition. Front
Oncol. 12(834235)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cheng X, Yang F, Li Y, Cao Y, Zhang M, Ji
J, Bai Y, Li Q, Yu Q and Gao D: The crosstalk role of CDKN2A
between tumor progression and cuproptosis resistance in colorectal
cancer. Aging (Albany NY). 16:10512–10538. 2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Joint Committee for the Revision of the
Japanese Oral Cancer Treatment Guidelines: The Clinical Practice
Guidelines for Oral Cancer. Kanehara & Co., Ltd., Tokyo,
pp19-62, 2023. https://www.sciencedirect.com/science/article/pii/S0901502724004466.
|
